PRELUDE CAPITAL MANAGEMENT, LLC - ATEA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$192,624
+113.9%
64,208
+166.7%
0.01%
+116.7%
Q2 2023$90,052
-5.7%
24,078
-15.5%
0.01%0.0%
Q1 2023$95,475
+32.6%
28,500
+179.5%
0.01%
+200.0%
Q2 2022$72,000
-2.7%
10,196
-0.0%
0.00%0.0%
Q1 2022$74,00010,2000.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,485,638$22,222,0001.76%
EcoR1 Capital, LLC 5,376,134$48,063,0001.53%
Cormorant Asset Management, LP 1,679,442$15,014,0000.89%
CM Management, LLC 100,000$894,0000.68%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 596,800$5,335,0000.40%
PDT Partners, LLC 278,487$2,490,0000.19%
Ikarian Capital, LLC 116,600$1,043,0000.16%
HighVista Strategies LLC 20,659$185,0000.15%
Aristides Capital LLC 35,132$314,0000.14%
Parkwood LLC 71,932$643,0000.11%
View complete list of ATEA PHARMACEUTICALS INC shareholders